Skip to Content

Interferon Gamma-1b

In the US, Interferon Gamma-1b (interferon gamma-1b systemic) is a member of the drug class interferons and is used to treat Chronic Granulomatous Disease, Cutaneous T-cell Lymphoma, Idiopathic Pulmonary Fibrosis, Osteopetrosis and Rheumatoid Arthritis.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Antineoplastic agent

Biological response modifier, BRM


Foreign Names

  • Interferonum gamma-1b (Latin)
  • Interferon-gamma-1b (German)
  • Interféron gamma-1 (French)
  • Interferón-gamma-1b (Spanish)

Generic Names

  • Interferon Gamma-1b (OS: USAN, BAN)
  • IFNgamma1b (IS)
  • Interferon Gamma-2a (IS)
  • Interferoni gamma-1b (IS)
  • r-IFN-Famma-1b (IS)
  • Interféron gamma-1b (solution concentrée d') (PH: Ph. Eur. 8)
  • Interferon Gamma-1b Concentrated Solution (PH: BP 2016)
  • Interferon gamma-1b concentrated solution (PH: Ph. Eur. 8)
  • Interferon-gamma-1b-Lösung, Konzentrierte (PH: Ph. Eur. 8)
  • Interferoni gamma-1b solutio concentrata (PH: Ph. Eur. 8)

Brand Names

  • Actimmune
    Vidara Therapeutics, United States
  • Immukin
    Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Malta
  • Immukine
    Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Netherlands
  • Imukin
    Boeh.Ingel., Argentina; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, France; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Norway; Boehringer Ingelheim, New Zealand; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim España, Spain; Boehringer Ingelheim International, Germany; Boehringer Ingelheim RCV, Austria


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.